CCA
ZBH icon

Catalyst Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Catalyst Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-208
Closed -$22.5K – 587
2024
Q3 		$22.5K Buy
+208
New +$22.7K ﹤0.01% 435
2016
Q2 		– Sell
-3,914
Closed -$405K – 556
2016
Q1 		$405K Buy
+3,914
New +$379K 0.07% 213

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Catalyst Capital Advisors's ZBH Position: Q4 2024 in Review

Catalyst Capital Advisors sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 208 shares — an estimated $22.5K sold.

Catalyst Capital Advisors first reported a position in ZBH in Q1 2016 and held it in 2 quarters. The position peaked at $405K in Q1 2016. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Catalyst Capital Advisors reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • Catalyst Capital Advisors sold 208 Zimmer Biomet shares in Q4 2024, an estimated $22.5K.
  • Catalyst Capital Advisors first reported a position in Zimmer Biomet in Q1 2016 and held it in 2 quarters.
  • Catalyst Capital Advisors's Zimmer Biomet position peaked at $405K in Q1 2016.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Catalyst Capital Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.